We are live on
!
Find out more
GPCM
Granite Point Capital Management Portfolio holdings
AUM
$4.9M
1-Year Est. Return
38.41%
This Fund
S&P 500
This Quarter
Est. Return
+9.86%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$1.51B
AUM Growth
+$391M
(+35%)
Cap. Flow
+$326M
Cap. Flow
% of AUM
21.64%
Top 10 Holdings %
Top 10 Hldgs %
67.36%
Holding
152
New
35
Increased
21
Reduced
38
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Beasley Broadcasting Group
BBGI
|
+$3.57M |
| 2 |
EverQuote
EVER
|
+$2.92M |
| 3 |
RUBY
Rubius Therapeutics, Inc
RUBY
|
+$2.71M |
| 4 |
argenx
ARGX
|
+$2.22M |
| 5 |
YRD
Yiren Digital
YRD
|
+$1.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$11.2M |
| 2 |
SPDR Gold Trust
GLD
|
+$4.15M |
| 3 |
Axogen
AXGN
|
+$3.67M |
| 4 |
Tandem Diabetes Care
TNDM
|
+$2.97M |
| 5 |
Senseonics Holdings Inc
SENS
|
+$2.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.2% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Communication Services | 1.81% |
| 4 | Technology | 1.78% |
| 5 | Energy | 0.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRNS
26
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $8.78M | 0.58% |
219,500
+184,250
| +523% | +$5.24M |
|
|
GOOS
27
Canada Goose Holdings
GOOS
$872M
| $6.28M | 0.42% |
97,300
-6,500
| -6% | -$379K |
|
28
Xenon Pharmaceuticals
XENE
$6.06B
| $6.13M | 0.41% |
464,300
-17,900
| -4% | -$207K |
|
|
29
Tandem Diabetes Care
TNDM
$1.34B
| $6M | 0.4% |
140,000
-85,000
| -38% | -$2.97M |
|
30
Meta Platforms (Facebook)
META
$1.42T
| $5.96M | 0.4% |
36,250
+7,600
| +27% | +$1.38M |
|
31
Amazon
AMZN
$2.92T
| $5.01M | 0.33% |
50,000
-4,000
| -7% | -$376K |
|
|
TELL
32
DELISTED
Tellurian Inc.
TELL
| $4.87M | 0.32% |
543,100
-230,000
| -30% | -$1.9M |
|
33
International Money Express
IMXI
$357M
| $4.81M | 0.32% |
400,000
| – | – |
|
|
ZGNX
34
DELISTED
Zogenix, Inc.
ZGNX
| $4.74M | 0.31% |
95,600
-2,900
| -3% | -$148K |
|
|
35
Senseonics Holdings Inc
SENS
$263M
| $4.47M | 0.3% |
46,820
-35,680
| -43% | -$2.92M |
|
36
Golar LNG
GLNG
$5B
| $3.99M | 0.26% |
143,400
-52,800
| -27% | -$1.4M |
|
|
ADMS
37
DELISTED
Adamas Pharmaceuticals
ADMS
| $3.9M | 0.26% |
194,715
-7,400
| -4% | -$174K |
|
|
YRD
38
Yiren Digital
YRD
$97.1M
| $3.59M | 0.24% |
195,000
+95,000
| +95% | +$1.73M |
|
39
Regenxbio
RGNX
$620M
| $3.59M | 0.24% |
47,500
-2,600
| -5% | -$187K |
|
40
lululemon athletica
LULU
$13.5B
| $3.51M | 0.23% |
21,600
-2,400
| -10% | -$329K |
|
|
41
Axogen
AXGN
$2.27B
| $3.5M | 0.23% |
94,976
-83,975
| -47% | -$3.67M |
|
42
Noodles & Co
NDLS
$111M
| $3.33M | 0.22% |
34,375
+6,250
| +22% | +$579K |
|
43
Sarepta Therapeutics
SRPT
$1.57B
| $3.31M | 0.22% |
20,500
-7,220
| -26% | -$987K |
|
|
44
Beasley Broadcasting Group
BBGI
$37.8M
| $3.1M | 0.21% |
+22,500
| New | +$3.57M |
|
|
AGS
45
DELISTED
PlayAGS
AGS
| $2.93M | 0.19% |
99,365
-11,000
| -10% | -$326K |
|
|
46
EverQuote
EVER
$892M
| $2.86M | 0.19% |
+192,600
| New | +$2.92M |
|
|
RUBY
47
DELISTED
Rubius Therapeutics, Inc
RUBY
| $2.85M | 0.19% |
+118,700
| New | +$2.71M |
|
48
MACOM Technology Solutions
MTSI
$19.2B
| $2.79M | 0.18% |
135,200
+20,000
| +17% | +$448K |
|
|
SBBP
49
DELISTED
Strongbridge Biopharma plc.
SBBP
| $2.75M | 0.18% |
567,895
| – | – |
|
|
EVBG
50
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.71M | 0.18% |
46,950
| – | – |
|
Similar funds
MAM
CCM
BGCI
CAM
EAM
SM
TPL
RC
Granite Point Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Granite Point Capital Management held 152 positions worth $1.51B, up 35% from $1.12B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Granite Point Capital Management deployed $326M of net new capital in Q3 2018, opening 35 new positions and adding to 21 existing holdings. Its largest new stake was Beasley Broadcasting Group: 22,500 shares worth $3.1M.
By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, down from 5.4% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Marinus Pharmaceuticals, Inc, an estimated $11.2M trimmed.
- Granite Point Capital Management's largest Q3 2018 buy was Beasley Broadcasting Group: 22,500 shares worth $3.1M.
- Granite Point Capital Management added most to Yiren Digital in Q3 2018, an estimated $1.73M increase.
- Granite Point Capital Management's biggest Q3 2018 reduction was Marinus Pharmaceuticals, Inc, cutting an estimated $11.2M.
- Granite Point Capital Management fully exited SPDR Gold Trust in Q3 2018, selling an estimated $4.15M.
- Granite Point Capital Management's ten largest holdings make up 67% of its $1.51B portfolio in Q3 2018.
- Granite Point Capital Management opened 35 new positions and closed 37 in Q3 2018.
- Granite Point Capital Management's portfolio value rose 35% quarter-over-quarter to $1.51B.
Based on Granite Point Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.